Skip to main navigation Skip to search Skip to main content

Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer

  • Mysore S. Veena
  • , Santanu Raychaudhuri
  • , Saroj K. Basak
  • , Natarajan Venkatesan
  • , Parameet Kumar
  • , Roopa Biswas
  • , Rita Chakrabarti
  • , Jing Lu
  • , Trent Su
  • , Marcus Gallagher-Jones
  • , Marco Morselli
  • , Haiqing Fu
  • , Matteo Pellegrini
  • , Theodore Goldstein
  • , Mirit I. Aladjem
  • , Matthew B. Rettig
  • , Sharon P. Wilczynski
  • , Daniel Sanghoon Shin
  • , Eri S. Srivatsan*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Wehave observed overexpression of PACS-1, a cytosolic sorting protein in primary cervical tumors. Absence of exonic mutations and overexpression at the RNA level suggested a transcriptional and/or posttranscriptional regulation. University of California Santa Cruz genome browser analysis of PACS-1 micro RNAs (miR), revealed two 8-base target sequences at the 39 terminus for hsa-miR-34a and hsa-miR-449a.Quantitative RT-PCR and Northern blotting studies showed reduced or loss of expression of the two microRNAs in cervical cancer cell lines and primary tumors, indicating dysregulation of these two microRNAs in cervical cancer. Loss of PACS-1 with siRNA or exogenous expression of hsamiR- 34a or hsa-miR-449a in HeLa and SiHa cervical cancer cell lines resulted in DNA damage response, S-phase cell cycle arrest, and reduction in cell growth. Furthermore, the siRNA studies showed that loss of PACS-1 expression was accompanied by increased nuclear γH2AX expression, Lys382-p53 acetylation, and genomic instability. PACS-1 re-expression through LNA-hsa-antimiR- 34a or -449a or through PACS-1 cDNA transfection led to the reversal of DNA damage response and restoration of cell growth. Release of cells post 24-h serumstarvation showed PACS- 1 nuclear localization at G1-S phase of the cell cycle. Our results therefore indicate that the loss of hsa-miR-34a and hsa-miR-449a expression in cervical cancer leads to overexpression of PACS-1 and suppression of DNA damage response, resulting in the development of chemo-resistant tumors.

Original languageEnglish
Pages (from-to)17169-17186
Number of pages18
JournalJournal of Biological Chemistry
Volume295
Issue number50
DOIs
StatePublished - 11 Dec 2020

Fingerprint

Dive into the research topics of 'Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer'. Together they form a unique fingerprint.

Cite this